Etrasimod for treating moderately to severely active ulcerative colitis in people aged 16 and over

  • Technology appraisal guidance
  • TA956
  • Published: 

History

Documents created during the development process.

Expected publication

Final draft guidance

Invitation to participate

Notes

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Topic selection